Table 4.
Baseline variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Odds ratio | 95%CI | P | Odds ratio | 95%CI | P | |
Age (years) | 0.973 | 0.938–1.009 | 0.14 | |||
Sex | 0.713 | 0.275–1.850 | 0.49 | |||
T1 | 1.007 | 0.998–1.016 | 0.12 | |||
T2 | 1.004 | 0.997–1.012 | 0.27 | |||
ALT | 1.015 | 0.990–1.042 | 0.24 | |||
Glucose | 0.899 | 0.734–1.101 | 0.30 | |||
Creatinine | 0.980 | 0.956–1.005 | 0.11 | |||
Uric acid | 1.008 | 1.002–1.014 | 0.01 | 1.008 | 1.002–1.014 | 0.01 |
Lymphocytes | 2.677 | 0.986–7.266 | 0.05 | |||
Platelet | 1.009 | 1.000–1.018 | 0.05 | |||
CD4+T cells | 1.002 | 1.000–1.004 | 0.04 | |||
CD8+T cells | 1.003 | 1.000–1.006 | 0.03 | |||
B cells | 1.003 | 0.999–1.007 | 0.20 |
CI, 95% confidence interval; T1, duration from the first infection of vaccine to diagnosis; T2, duration from the second infection of vaccine to diagnosis; ALT, alanine aminotransferase